Mesoblast Limited (MESO)
$14.29+3.93%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.9B
- Beta
- 0.81
- P/E (TTM)
- -31.76
- Short % float
- 4.01%
- Days to cover
- 15.4
- SI change
- -0.2%
- 1W
- +1.49%
- 1M
- -7.81%
- vs SPY 1W
- +0.33%
- vs SPY 1M
- -10.80%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MESO?
- LOPJLB’s latest quantitative signal on Mesoblast Limited (MESO) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is MESO in?
- Mesoblast Limited (MESO) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Mesoblast Limited (MESO) do?
- Mesoblast Limited is a biopharmaceutical firm dedicated to the development and commercialization of allogeneic cell-based therapies. Its global presence extends across the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company addresses a broad spectrum of medical conditions, including cardiovascular, spinal orthopedic disorders, oncology, hematology, and immune-m…